This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
On-demand Medical Crossfire® activity
Developing Individualized Asthma Action Plans for the Severe Uncontrolled Patient in an Era of Targeted Therapy
Peter Salgo, MD
Professor of Medicine and Anesthesiology
Columbia University College of Physicians and Surgeons
New York, New York
Natasha McClure, DNP, RN, CPNP
Vanderbilt University School of Nursing
Michael E Wechsler, MD
Professor of Medicine
Director, Asthma Program
Co-Director, Cohen Family NJH Asthma Institute
National Jewish Health
Clinton Township, Michigan
During this Medical Crossfire, expert faculty a will engage in a multidisciplinary roundtable discussion that includes a pulmonologist, primary care clinician, nurse practitioner and a patient advocate to discuss how to best optimize and individualize asthma management. A focus will be placed on managing the severe, uncontrolled asthma patient.
At the completion of this activity, the participant will be able to:
Articulate the importance of providing self-management education and AAP to asthma patients
Appropriately evaluate patients with asthma for level of control, asthma severity, and risk of exacerbations
Explore the current guidelines for asthma treatment
Differentiate between the different biologics based on mechanism of action and phenotypes
Describe how to make individualized treatment selections in patients with uncontrolled asthma that appropriately address the impact of underlying inflammation
Physicians, Nurses, Nurse Practitioners, and Physician Assistants
May 15, 2017
May 15, 2018
Length of Webinar:
This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.
How to Obtain Credit
To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online post-test and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit before May 19, 2018. CE credit will not be issued after this date
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians' Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 2.0 AMA PRA Category1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is accredited for 2.0 contact hour(s) which includes 0.0 hour(s) of pharmacology.
Activity ID #2304E
This activity was planned in accordance with AANP CE Standards and Policies.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Fee Information& Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Michael E. Wechsler, MD
has the following relevant financial relationships with commercial interest to disclose:
- Grant/Research Support: Sanofi/Regeneron
- Consultant: AstraZeneca, Teva, Boston Scientific, Boehringer Ingelgeim, Genetech, Novartis, Viateris, Gilacure
The following contributors have no relevant financial relationships with commercial interests to disclose.
Peter Salgo, MD
Natasha McClure, DNP, RN, CPNP
Physicians' Education Resource®, LLC (PER®)
Dave Heckard, Maryjo Dixon, RPh, Donna Fausak, and Nicole Grassano.
Global Education Group Planners/Mangers
: Kristen Delisi, NP, Ashley Marostica, RN, MSN, Andrea Funk.
Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.